Literature DB >> 28769220

SUBACUTE SCLEROSING PANENCEPHALITIS (A Report on Two Cases).

Mkk Rao1, R K Gupta2, V C Ohri3, S Narayan4, Sangeeta Joshi5.   

Abstract

We report two cases of subacute sclerosing panencephalitis (SSPE) which is a rare, late neurological sequel, of measles infection acquired in childhood. The diagnosis was reached by adopting criteria defined by Dyken. Past history of measles was present in both the cases and they showed high titres of measles specific antibody in CSF and serum by quantitative ELISA.

Entities:  

Keywords:  Measles; SSPE

Year:  2017        PMID： 28769220      PMCID： PMC5529724          DOI： 10.1016/S0377-1237(17)31092-4

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


  6 in total

1.  High incidence of subacute sclerosing panencephalitis in south India.

Authors:  V Saha; T J John; P Mukundan; C Gnanamuthu; S Prabhakar; G Arjundas; Z A Sayeed; G Kumaresan; K Srinivas
Journal:  Epidemiol Infect       Date:  1990-02       Impact factor: 2.451

2.  Measles-virus antibody and antigen in subacute sclerosing panencephalitis.

Authors:  J H Connolly; I V Allen; L J Hurwitz; J H Millar
Journal:  Lancet       Date:  1967-03-11       Impact factor: 79.321

3.  Neurologic disorders following live measles-virus vaccination.

Authors:  P J Landrigan; J J Witte
Journal:  JAMA       Date:  1973-03-26       Impact factor: 56.272

4.  Subacute sclerosing panencephalitis in Chandigarh.

Authors:  S Broor; S R Pal; A K Banerjee; N L Chitkara; S Choudhury; J S Chopra; K Radha Krishnan
Journal:  Indian J Med Res       Date:  1979-10       Impact factor: 2.375

5.  Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients.

Authors:  C E Jones; P R Dyken; P R Huttenlocher; J T Jabbour; K W Maxwell
Journal:  Lancet       Date:  1982-05-08       Impact factor: 79.321

6.  Serodiagnosis of subacute sclerosing panencephalitis by enzyme linked immunosorbent assay.

Authors:  V Lakshmi; Y Malathy; R R Rao
Journal:  Indian J Pediatr       Date:  1993 Jan-Feb       Impact factor: 1.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.